Allogene Therapeutics, Inc. - ALLO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 02, 2026 | SVP, Chief Technical Officer | S | D | 2,867.0 | 2.5 | 7,167.5 | 195,338.0 | View | |
| Mar 18, 2026 | SVP, Chief Technical Officer | S | D | 4,835.0 | 2.47 | 11,942.45 | 198,205.0 | View | |
| Mar 18, 2026 | President and CEO | S | D | 47,763.0 | 2.47 | 117,974.61 | 5,150,599.0 | View | |
| Mar 04, 2026 | SVP, Chief Technical Officer | S | D | 7,132.0 | 2.6 | 18,543.2 | 203,040.0 | View | |
| Feb 04, 2026 | SVP, Chief Technical Officer | A | A | 105,720.0 | 0.0 | 0.0 | 105,720.0 | View | |
| Feb 04, 2026 | SVP, Chief Technical Officer | A | A | 373,757.0 | 0.0 | 0.0 | 373,757.0 | View | |
| Feb 04, 2026 | SVP, Chief Technical Officer | S | D | 7,549.0 | 1.73 | 13,059.77 | 210,172.0 | View | |
| Feb 04, 2026 | EVP of R&D | A | A | 203,307.0 | 0.0 | 0.0 | 203,307.0 | View | |
| Feb 04, 2026 | EVP of R&D | A | A | 718,763.0 | 0.0 | 0.0 | 718,763.0 | View | |
| Feb 04, 2026 | EVP of R&D | S | D | 35,700.0 | 1.77 | 63,189.0 | 581,166.0 | View | |
| Feb 04, 2026 | — | A | A | 263,033.0 | 0.0 | 0.0 | 263,033.0 | View | |
| Feb 04, 2026 | — | A | A | 929,913.0 | 0.0 | 0.0 | 929,913.0 | View | |
| Feb 04, 2026 | SVP, General Counsel | A | A | 152,480.0 | 0.0 | 0.0 | 152,480.0 | View | |
| Feb 04, 2026 | SVP, General Counsel | A | A | 539,072.0 | 0.0 | 0.0 | 539,072.0 | View | |
| Feb 04, 2026 | SVP, General Counsel | S | D | 22,900.0 | 1.76 | 40,304.0 | 564,948.0 | View | |
| Feb 04, 2026 | CHIEF FINANCIAL OFFICER | A | A | 152,480.0 | 0.0 | 0.0 | 152,480.0 | View | |
| Feb 04, 2026 | CHIEF FINANCIAL OFFICER | A | A | 539,072.0 | 0.0 | 0.0 | 539,072.0 | View | |
| Feb 04, 2026 | CHIEF FINANCIAL OFFICER | S | D | 24,001.0 | 1.76 | 42,241.76 | 1,252,795.0 | View | |
| Feb 04, 2026 | President and CEO | A | A | 392,586.0 | 0.0 | 0.0 | 392,586.0 | View | |
| Feb 04, 2026 | President and CEO | A | A | 1,387,931.0 | 0.0 | 0.0 | 1,387,931.0 | View | |
| Feb 04, 2026 | President and CEO | S | D | 95,269.0 | 1.8 | 171,484.2 | 5,185,862.0 | View | |
| Feb 04, 2026 | SVP, Finance | A | A | 50,827.0 | 0.0 | 0.0 | 50,827.0 | View | |
| Feb 04, 2026 | SVP, Finance | A | A | 179,691.0 | 0.0 | 0.0 | 179,691.0 | View | |
| Feb 04, 2026 | SVP, Finance | S | D | 4,167.0 | 1.72 | 7,167.24 | 130,322.0 | View | |
| Jan 23, 2026 | EVP of R&D | S | D | 26,269.0 | 1.56 | 40,979.64 | 616,866.0 | View | |
| Dec 22, 2025 | — | M | D | 47,700.0 | 0.0 | 0.0 | 47,700.0 | View | |
| Dec 22, 2025 | — | M | A | 47,700.0 | 0.0 | 0.0 | 350,763.0 | View | |
| Nov 19, 2025 | SVP, Chief Technical Officer | S | D | 786.0 | 1.22 | 958.92 | 217,721.0 | View | |
| Oct 23, 2025 | CHIEF FINANCIAL OFFICER | S | D | 36,744.0 | 1.2565 | 46,168.84 | 1,276,796.0 | View |